Jingwei Yu, PhD, MD

Professor of Clin Lab, Cytogenetics Laboratory Director
Laboratory Medicine
Specialty Areas
Cytogenetics

UCSF
Laboratory Medicine, Box 0134
185 Berry Street, Suite 290
San Francisco, CA 94143
United States

UCSF Directory

Hospital Affiliations
UCSF Parnassus Heights
Research and Clinical Interests

Genomic and epigenetic analysis of cancer and chromosome disorders, development of chromosomal and molecular markers for clinical diagnosis.

Selected Publications
  • Lu CM, Zhou L, Feng S, Kohn PH, Qi Z and Yu J. Presence of complex t(6;9;22;15) four-way chromosome rearrangements plus a rare t(1;6) translocation does not affect the response to imatinib therapy in chronic myelogenous leukemia. Leukemia and Lymphoma. 2011 November; 52(11):2182-4.
  • Huang V, Place RF, PortnoyV, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J and Li LC. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Research, 2012 February: 40(4):1695-1707.
  • Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, Yu J, Yeh R-F, Hebrok M and Ramalho-Santos M. Transcriptional Analysis of Pluripotency Reveals the Hippo Pathway as a Barrier to Reprogramming. Human Molecular Genetics. 2012 May 1;21(9):2054-67.
  • Ye L, Muench MO, Fusaki N, Beyer AI, Wang J, Qi Z, Yu J and Kan YW. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Trans Med. 2013 (in press).
  • Huang V, Zheng J, Qi Z, Wang J, Place RP, Yu J, Li H and Li LC. Ago1 interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genetics, 2013 (in press).